Figure 1.
Risk of ICH in patients with primary or metastatic brain cancer treated with or without anticoagulants.

Risk of ICH in patients with primary or metastatic brain cancer treated with or without anticoagulants.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal